Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$12.84 - $17.26 $1.44 Million - $1.94 Million
-112,152 Reduced 32.28%
235,251 $3.51 Million
Q4 2020

Feb 16, 2021

SELL
$14.61 - $17.59 $1.66 Million - $2 Million
-113,794 Reduced 24.67%
347,403 $5.22 Million
Q3 2020

Nov 16, 2020

SELL
$11.64 - $16.86 $3.07 Million - $4.44 Million
-263,506 Reduced 36.36%
461,197 $7.63 Million
Q2 2020

Aug 14, 2020

BUY
$7.75 - $22.61 $4.09 Million - $11.9 Million
527,391 Added 267.29%
724,703 $9.39 Million
Q1 2020

May 15, 2020

SELL
$5.39 - $18.33 $22,417 - $76,234
-4,159 Reduced 2.06%
197,312 $1.54 Million
Q4 2019

Feb 14, 2020

BUY
$11.26 - $13.8 $2.27 Million - $2.78 Million
201,471 New
201,471 $2.61 Million

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $55.4M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.